Outcomes in patients tested for Clostridium difficile toxins

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 4, 2012, Pages 369-373

  Polage, Christopher R ^a   Chin, David L ^a   Leslie, Jhansi L ^a   Tang, Jevon ^a   Cohen, Stuart H ^a   Solnick, Jay V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clostridium difficile; Diarrhea; Healthcare associated infection; Outcomes; Toxin

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; METRONIDAZOLE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CHILD; CLINICAL EVALUATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION CONTROL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84869080321     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.08.019     Document Type: Article

References (41)

1. Agency for Healthcare Research and Quality (AHRQ) Comorbidity Software, Version 3.6, H-CUP 2011, Agency for Healthcare Research and Quality (AHRQ), Rockville, MD.
2. Akerlund T., Svenungsson B., Lagergren A., Burman L.G. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol 2006, 44:353-358.
3. Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002, 346:334-339.
4. Bowman R.A., Riley T.V. Isolation of Clostridium difficile from stored specimens and comparative susceptibility of various tissue culture cell lines to cytotoxin. FEMS Microbiol Lett 1986, 34:31-35.
5. Campbell R.J., Giljahn L., Machesky K., Cibulskas-White K., Lane L.M., Porter K., et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009, 30:526-533.
6. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
7. Dallal R.M., Harbrecht B.G., Boujoukas A.J., Sirio C.A., Farkas L.M., Lee K.K., et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002, 235:363-372.
8. Delmee M., Van Broeck J., Simon A., Janssens M., Avesani V. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 2005, 54:187-191.
9. Dubberke E.R., Han Z., Bobo L., Hink T., Lawrence B., Copper S., et al. Impact of clinical symptoms on the interpretation of diagnostic assays for Clostridium difficile. J Clin Microbiol 2011, 49:2887-2893.
10. Eastwood K., Else P., Charlett A., Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009, 47:3211-3217.
11. Elixhauser A., Jhung M. Statistical brief #50: Clostridium difficile-associated disease in U.S. hospitals, 1993-2005 2008, Agency for Healthcare Research and Quality (AHRQ) Rockville, MD, (http://www.hcup-us.ahrq.gov/reports/statbriefs/sb50.jsp; Last accessed September 14, 2012).
12. Elixhauser A., Steiner C., Harris D.R., Coffey R.M. Comorbidity measures for use with administrative data. Med Care 1998, 36:8-27.
13. Garey K.W., Graham G., Gerard L., Dao T., Jiang Z.D., Price M., et al. Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother 2006, 40:1030-1034.
14. Gerding D.N., Olson M.M., Peterson L.R., Teasley D.G., Gebhard R.L., Schwartz M.L., et al. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med 1986, 146:95-100.
15. Gerding D.N., Johnson S., Peterson L.R., Mulligan M.E., Silva J. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995, 16:459-477.
16. Gilligan P.H. Is a two-step glutamate dehydrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile?. J Clin Microbiol 2008, 46:1523-1525.
17. Guerrero D.M., Chou C., Jury L.A., Nerandzic M.M., Cadnum J.C., Donskey C.J. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin. Clin Infect Dis 2011, 53:287-290.
18. Jarvis W.R., Schlosser J., Jarvis A.A., Chinn R.Y. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009, 37:263-270.
19. Kaltsas A., Simon M., Unruh L.H., Son C., Wroblewski D., Musser K.A., et al. Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic results. J Clin Microbiol 2012, 50:1303-1307.
20. Kuehne S.A., Cartman S.T., Heap J.T., Kelly M.L., Cockayne A., Minton N.P. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010, 467:711-713.
21. Kufelnicka A.M., Kirn T.J. Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection. Clin Infect Dis 2011, 52:1451-1457.
22. Kyne L., Warny M., Qamar A., Kelly C.P. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000, 342:390-397.
23. Lemee L., Dhalluin A., Testelin S., Mattrat M.A., Maillard K., Lemeland J.F., et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 2004, 42:5710-5714.
24. Lyras D., O'Connor J.R., Howarth P.M., Sambol S.P., Carter G.P., Phumoonna T., et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009, 458:1176-1179.
25. McDonald L.C., Owings M., Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006, 12:409-415.
26. McFarland L.V. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control 1995, 23:295-305.
27. McFarland L.V., Mulligan M.E., Kwok R.Y., Stamm W.E. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989, 320:204-210.
28. Pepin J., Valiquette L., Alary M.E., Villemure P., Pelletier A., Forget K., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004, 171:466-472.
29. Peterson L.R., Manson R.U., Paule S.M., Hacek D.M., Robicsek A., Thomson R.B., et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 2007, 45:1152-1160.
30. Reller M.E., Lema C.A., Perl T.M., Cai M., Ross T.L., Speck K.A., et al. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 2007, 45:3601-3605.
31. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
32. Ryder A.B., Huang Y., Li H., Zheng M., Wang X., Stratton C.W., et al. Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system. J Clin Microbiol 2010, 48:4129-4134.
33. Samore M.H., DeGirolami P.C., Tlucko A., Lichtenberg D.A., Melvin Z.A., Karchmer A.W. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994, 18:181-187.
34. Sharp S., Gilligan P.H. A practical guidance document for the laboratory detection of toxigenic Clostridium difficile 2010, ASM Public and Scientific Affairs Board (PSAB) Committee on Laboratory Practices, American Society for Microbiology (ASM), Washington, D.C., (http://archive.asm.org/images/pdf/Clinical/clostridiumdifficile9-21.pdf; Last accessed on September 14, 2012).
35. Sloan L.M., Duresko B.J., Gustafson D.R., Rosenblatt J.E. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 2008, 46:1996-2001.
36. Steiner T.S., Flores C.A., Pizarro T.T., Guerrant R.L. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol 1997, 4:719-722.
37. Tenover F.C., Novak-Weekley S., Woods C.W., Peterson L.R., Davis T., Schreckenberger P., et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 2010, 48:3719-3724.
38. van den Berg R.J., Vaessen N., Endtz H.P., Schulin T., van der Vorm E.R., Kuijper E.J. Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. J Med Microbiol 2007, 56:36-42.
39. Viscidi R., Willey S., Bartlett J.G. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981, 81:5-9.
40. Wilcox M.H., Planche T., Fang F.C., Gilligan P.H. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection?. J Clin Microbiol 2010, 48:4347-4353.
41. Yadav Y., Garey K.W., Dao-Tran T.K., Kaila V., Gbito K.Y., DuPont H.L. Automated system to identify Clostridium difficile infection among hospitalized patients. J Hosp Infect 2009, 72:337-341.